Insights

Growing Market Expansion Cytovance Biologics has recently expanded its facilities within Oklahoma, indicating a focus on scaling its manufacturing capabilities to meet increasing client demand, offering opportunities to provide complementary manufacturing solutions or capacity upgrades.

Strategic Collaborations The company's recent partnerships with PolyPeptide, ExcellGene, and Vectron Biosolutions demonstrate a commitment to enhancing peptide and microbial development services, creating potential sales avenues for advanced bioprocessing technologies and specialized strain development.

Product Diversification Cytovance’s focus on a broad range of biotherapeutics, including biosimilars, antibodies, vaccines, and enzymes, presents opportunities to tailor solutions across diverse therapeutic areas and expand line extensions or custom contract services.

Leadership & Vision New executive appointments such as the CEO and Chief Commercial Officer suggest strategic growth and increased market outreach, opening doors for innovative partnership proposals and collaborative ventures in biologics manufacturing.

Recent Technology Focus Partnerships in peptide and strain development highlight a drive toward advancing bioprocessing expertise, offering prospects to introduce next-gen biomanufacturing technologies, custom strain engineering, and process development services to support client innovation.

Cytovance Biologics Tech Stack

Cytovance Biologics uses 8 technology products and services including D2L Brightspace, Sucuri, HubSpot Cookie Policy Banner, and more. Explore Cytovance Biologics's tech stack below.

  • D2L Brightspace
    Communication And Collaboration
  • Sucuri
    Content Delivery Network
  • HubSpot Cookie Policy Banner
    Cookie Compliance
  • jQuery
    Javascript Libraries
  • Microsoft Word
    Office Suites
  • Smartsheet
    Project Management
  • Adobe Acrobat DC
    Rich Text Editors
  • Adobe Creative Suite
    Visualisation Software

Media & News

Cytovance Biologics's Email Address Formats

Cytovance Biologics uses at least 1 format(s):
Cytovance Biologics Email FormatsExamplePercentage
FLast@cytovance.comJDoe@cytovance.com
93%
Last.First@cytovance.comDoe.John@cytovance.com
4%
LFirst@cytovance.comDJohn@cytovance.com
1%
Last@cytovance.comDoe@cytovance.com
2%

Frequently Asked Questions

Where is Cytovance Biologics's headquarters located?

Minus sign iconPlus sign icon
Cytovance Biologics's main headquarters is located at 800 Research Pkwy, Oklahoma City, OK 73104, US. The company has employees across 2 continents, including North AmericaAsia.

What is Cytovance Biologics's phone number?

Minus sign iconPlus sign icon
You can contact Cytovance Biologics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Cytovance Biologics's official website and social media links?

Minus sign iconPlus sign icon
Cytovance Biologics's official website is cytovance.com and has social profiles on LinkedInCrunchbase.

How much revenue does Cytovance Biologics generate?

Minus sign iconPlus sign icon
As of October 2025, Cytovance Biologics's annual revenue is estimated to be $27M.

What is Cytovance Biologics's SIC code NAICS code?

Minus sign iconPlus sign icon
Cytovance Biologics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Cytovance Biologics have currently?

Minus sign iconPlus sign icon
As of October 2025, Cytovance Biologics has approximately 201 employees across 2 continents, including North AmericaAsia. Key team members include Chief Executive Officer: P. Z.Chief Commercial Officer (cco): A. S.Chief Financial Officer: S. W.. Explore Cytovance Biologics's employee directory with LeadIQ.

What industry does Cytovance Biologics belong to?

Minus sign iconPlus sign icon
Cytovance Biologics operates in the Biotechnology Research industry.

What technology does Cytovance Biologics use?

Minus sign iconPlus sign icon
Cytovance Biologics's tech stack includes D2L BrightspaceSucuriHubSpot Cookie Policy BannerjQueryMicrosoft WordSmartsheetAdobe Acrobat DCAdobe Creative Suite.

What is Cytovance Biologics's email format?

Minus sign iconPlus sign icon
Cytovance Biologics's email format typically follows the pattern of FLast@cytovance.com. Find more Cytovance Biologics email formats with LeadIQ.

How much funding has Cytovance Biologics raised to date?

Minus sign iconPlus sign icon
As of October 2025, Cytovance Biologics has raised $20M in funding. The last funding round occurred on Oct 28, 2014 for $20M.

When was Cytovance Biologics founded?

Minus sign iconPlus sign icon
Cytovance Biologics was founded in 2003.
Cytovance Biologics

Cytovance Biologics

Biotechnology ResearchUnited States201-500 Employees

Streamline your biomanufacturing programs with Cytovance Biologics! Born from a decades-long history in drug development, we believe in creating a healthier world where every biologic’s path to commercialization is advanced by a CDMO partner that delivers ingenuity end-to-end. Whether your large molecule product needs the flexibility of a customized approach or the efficiency of a predetermined platform process, Team Cytovance has the deep expertise in microbial and mammalian expression systems to support your scale-up at every stage.

From early needs like cell line development and strain selection to cGMP manufacturing for clinical and commercial production, our team is your team. Together, we will guide your asset through the complexities of manufacturing and deliver it to its next milestone.
With a 95% scale-up success rate and quality, scalability, and reproducibility top of mind, we bring a range of therapeutic proteins and antibodies to the clinic, including:
● Biosimilars
● Cytokines
● Enzymes/Hormones
● Fusion Proteins
● Bispecific, Fragment, and Monoclonal Antibodies
● Recombinant Protein
● Vaccines
● And More

We are the Responsible, Reliable, and Resourceful partner you and your product deserve.

Section iconCompany Overview

Headquarters
800 Research Pkwy, Oklahoma City, OK 73104, US
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2003
Employees
201-500

Section iconFunding & Financials

  • $20M

    Cytovance Biologics has raised a total of $20M of funding over 2 rounds. Their latest funding round was raised on Oct 28, 2014 in the amount of $20M.

  • $100M$250M

    Cytovance Biologics's revenue is estimated to be in the range of $100M$250M

Section iconFunding & Financials

  • $20M

    Cytovance Biologics has raised a total of $20M of funding over 2 rounds. Their latest funding round was raised on Oct 28, 2014 in the amount of $20M.

  • $100M$250M

    Cytovance Biologics's revenue is estimated to be in the range of $100M$250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.